[12] results for :

Oncology: 2015 ASH Review - Lymphoma Presented by Nancy L. Bartlett, MD
Live   |   1 Credit(s)

New Course
LEARNING OBJECTIVES Following the presentation, each participant should be able to: 1.Improve patient management through the introduction of new or updated knowledge, techniques, equipment, or drugs. 2.Identify appropriate procedures and treatments and attempt to modify behaviors, change practice patterns or raise awar

Release Date: 1/23/2017   |   End Date: 4/18/2018
Oncology: 2015 ASH Review What is Refractory AML Presented by Eli Estey, MD
Live

New Course
1.Improve patient management through the introduction of new or updated knowledge, techniques, equipment, or drugs. 2.Identify appropriate procedures and treatments and attempt to modify behaviors, change practice patterns or raise awareness of potential problems identified through M&M and/or continuous quality improvem

Release Date: 1/23/2017   |   End Date: 4/18/2018
Oncology: 2015 ASH Review Individualized Care of MPNs Presented by Ruben Mesa, MD, FACP
Live   |   1 Credit(s)

New Course
LEARNING OBJECTIVES Following the presentation, each participant should be able to: 1.Improve patient management through the introduction of new or updated knowledge, techniques, equipment, or drugs. 2.Identify appropriate procedures and treatments and attempt to modify behaviors, change practice patterns or raise awar

Release Date: 1/23/2017   |   End Date: 4/18/2018
Oncology: Neuroendocrine Tumors - Presented by Eric Liu, MD
Live

New Course
LEARNING OBJECTIVES Following the presentation, each participant should be able to: Describe the current and novel methods of diagnosing neuroendocrine tumors (NETS). Describe the current and novel methods of treating NETS. Explain current epidemiological and demographic data on NETS.

Release Date: 1/23/2017   |   End Date: 1/01/2018
Oncology: 2015 ASH Review Multiple Myeloma & Amyloidosis Presented by Jeffrey A. Zonder, MD
Live

New Course
2015 ASH Review Multiple Myeloma & Amyloidosis Presented by Jeffrey A. Zonder, MD

Release Date: 1/23/2017   |   End Date: 4/18/2018
Oncology: Phase 1 Clinical Trials in the Era of Targeted Cancer Therapy - Presented by Gerald Falchook, MD, MS
Enduring   |   1 Credit(s)

LEARNING OBJECTIVES Following the presentation, each participant should be able to: Discuss the goals of phase 1 clinical trials Differentiate phase 1 from phase 2 and 3 trials Describe the design of phase 1 trials Discuss safety and potential efficacy for patients who enroll on phase 1 trials.

Release Date: 11/05/2014   |   End Date: 11/05/2017
Oncology: Pancreatic Cyst Disease: What You Dont Know Can Hurt You - Presented by Eric O. Kortz, MD, FACS
Enduring   |   1 Credit(s)

LEARNING OBJECTIVES Following the presentation, each participant should be able to: The physician will explain the appropriate follow-up for a pancreatic cyst

Release Date: 8/07/2014   |   End Date: 8/07/2017
Oncology: Esophageal Adenocarcinoma: Preventing a Health Care Disaster Via Treatment of Early Disease - Presented by Ashwin A. Kurian, MD
Enduring   |   1 Credit(s)

LEARNING OBJECTIVES Following the presentation, each participant should be able to: Define the lung cancer screening criteria set by the National Lung Cancer Screening Trial.

Release Date: 8/07/2014   |   End Date: 8/07/2017
Oncology: Pulmonary Nodules - Presented by James J. Fenton, MD
Enduring   |   1 Credit(s)

LEARNING OBJECTIVES Following the presentation, each participant should be able to: Describe the management of lung nodules based on size.

Release Date: 8/07/2014   |   End Date: 8/07/2017
Oncology: Modern Medical Management of CNS Gilomas - Presented by Michael L. Pearlman, MD, Ph.D.
Enduring   |   1 Credit(s)

LEARNING OBJECTIVES Following the presentation, each participant should be able to: List the signs and symptoms of a potential brain tumor.

Release Date: 8/07/2014   |   End Date: 8/07/2017
Oncology: Risk Stratification and Treatment Modalities of Acute Myeloid Leukemia (AML) - Presented by Tara Gregory, MD - Hematology/Oncologist
Enduring   |   1 Credit(s)

LEARNING OBJECTIVES Following the presentation, each participant should be able to: 1.Explain the risk stratification of AML. 2.Describe the utility and role of allogeneic stem cell transplant in the transplant eligible patient. 3.Explain treatment options and goals for the stem cell ineligible patient.

Release Date: 8/06/2014   |   End Date: 8/06/2017
Oncology: Multiple Myeloma; Diagnosis and Treatment Strategies - Presented by Tara Gregory, MD
Enduring   |   1 Credit(s)

LEARNING OBJECTIVES Following the presentation, each participant should be able to: 1.Recognize the symptoms of Multiple Myeloma. 2.Describe the diagnostic testing for Multiple Myeloma. 3.Explain treatment and goals of treatment for Multiple Myeloma.

Release Date: 7/03/2014   |   End Date: 7/03/2017